Correction to Amgen Earnings Stories
28 October 2014 - 9:54AM
Dow Jones News
Amgen Inc. said its earnings increased in the third quarter,
driven by strong growth of key drugs such as cancer therapy
Kyprolis. "Amgen Posts Strong Results on Higher Sales--Update"
published at 5:39 p.m. and an earlier version at 4:01 p.m.
misspelled the name of drug as Krypolis in the lead of the
story.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2024 to May 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From May 2023 to May 2024